Mirae Asset Global ETFs Holdings
ALLO icon

Mirae Asset Global ETFs Holdings’s Allogene Therapeutics ALLO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
161,438
+68,552
+74% +$151K ﹤0.01% 2207
2026
Q1 		$222K Buy
92,886
+21,435
+30% +$43K ﹤0.01% 2307
2025
Q4 		$97.9K Sell
71,451
-93,329
-57% -$123K ﹤0.01% 2689
2025
Q3 		$204K Sell
164,780
-14,796
-8% -$17.6K ﹤0.01% 2308
2025
Q2 		$203K Sell
179,576
-106,457
-37% -$141K ﹤0.01% 2275
2025
Q1 		$418K Sell
286,033
-19,862
-6% -$37.4K ﹤0.01% 1961
2024
Q4 		$651K Buy
305,895
+58,331
+24% +$144K ﹤0.01% 1778
2024
Q3 		$695K Sell
247,564
-16,765
-6% -$44.7K ﹤0.01% 1744
2024
Q2 		$618K Buy
+264,329
New +$780K ﹤0.01% 1718

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TPG GP A
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ALLO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Allogene Therapeutics (ALLO) stake by 74% in Q2 2026, buying an estimated $151K and bringing the position to 161,438 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #2207.

Mirae Asset Global ETFs Holdings first reported a position in ALLO in Q2 2024 and has held it in 9 quarters since. The position peaked at $695K in Q3 2024. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 161,438 shares of Allogene Therapeutics worth $341K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 68,552 Allogene Therapeutics shares in Q2 2026, an estimated $151K.
  • Allogene Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2207 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Allogene Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Allogene Therapeutics position peaked at $695K in Q3 2024.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.